934
Participants
Start Date
October 31, 2022
Primary Completion Date
June 20, 2024
Study Completion Date
June 20, 2024
Beijing Cancer Hospital, Beijing
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
Peking Union Medical College Hospital, Beijing
Fudan University Shanghai Cancer Center, Shanghai
Zhongshan Hospital, Fudan University, Shanghai
Jiangsu Province Hospital, Nanjing
The First Affiliated Hospital of Soochow University, Suzhou
Qilu Hospital of Shandong University, Jinan
Affiliated Hospital of Qingdao University, Qingdao
Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin
Tianjin Medical University Cancer Hospital, Tianjin
Fujian Cancer Hospital, Fuzhou
Fujian Medical University Union Hospital, Fuzhou
Tongji Medical College of Hust, Wuhan
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Sun Yat-sen University Cancer Center, Guangzhou
West China Hospital of Sichuan University, Chengdu
Shanxi Cancer Hospital, Taiyuan
Lead Sponsor
Takeda
INDUSTRY